CPHI Korea 2027: pharmaceutical and biopharmaceutical trade fair

CPHI Korea returns from 24 to 26 August 2027 at COEX Hall D and Grand InterContinental Seoul Parnas in Seoul, South Korea. Organised by Informa Markets Korea, it is a business-to-business exhibition for pharmaceutical, biopharmaceutical and health-ingredient professionals. The 2027 edition is planned across two exhibition locations, following the organiser’s announcement that the show would expand beyond COEX to include Grand InterContinental Seoul Parnas. Check the organiser’s latest venue map and exhibitor information before planning appointments, because visitors may need to account for both locations.

CPHI Korea is more than a product display. It combines suppliers across pharmaceutical ingredients, finished dosage, bio, nutraceuticals, contract services, laboratory equipment, packaging and drug delivery with business meetings and an industry programme. Use the three days to compare specific products and capabilities, ask technical and commercial questions, and decide which conversations merit follow-up.

Why CPHI Korea matters to pharma professionals

Compare connected parts of the supply chain

The event’s stated sectors span active pharmaceutical ingredients (APIs), finished dosage forms (FDF), excipients, natural extracts, fine chemicals, integrated pharma, contract services, biopharma, lab machinery and equipment, packaging and drug delivery. Seeing these categories in one business setting can help visitors connect a formulation or production requirement with upstream materials, manufacturing support and equipment options. It does not replace technical qualification: suitability still depends on specifications, quality systems, regulatory status, capacity and commercial terms.

Meet suppliers and purchasing decision-makers

The organiser’s 2026 post-show report recorded 11,589 visitors from 65 countries and 478 exhibiting companies from 22 countries. It reported that 74% of visitors held purchasing decision-making authority and that 20.3% of visitors were international. Those are reported 2026 figures, not attendance promises for 2027. They indicate that the previous edition attracted a substantial business audience and a meaningful international component.

Connect exhibition visits with learning

CPHI/Hi Korea 2026 included 144 programme sessions: 41 conferences, 70 seminars and 33 investor-relations pitching sessions. The organiser highlighted sessions on health-functional-food policy, bio-health policy, innovative biopharma modalities, AI drug discovery and microneedle technology. These are examples from the previous edition, not a confirmed 2027 schedule. Use the 2027 agenda when released to choose sessions that complement supplier meetings rather than assume the same topics will return.

• 11,589 visitors from 65 countries in 2026, reported by the organiser.
• 478 exhibiting companies from 22 countries in 2026, reported by the organiser.
• 74% of 2026 visitors were reported as holding purchasing decision-making authority.
• 144 sessions were held in 2026: 41 conferences, 70 seminars and 33 IR pitches.
• For 2027, the organiser announced expectations of more than 450 exhibitors and over 12,000 visitors. These are forward-looking estimates, not confirmed results.

Who should visit CPHI Korea?

Choose your visit around the decisions you need to make. The 2026 visitor report showed interest across pharmaceuticals, health-functional foods, bio, and laboratory/analytical equipment and packaging; the event is not limited to one product category.

Pharmaceutical procurement and sourcing teams

Useful if you are assessing suppliers for APIs, excipients, finished dosage, fine chemicals, natural extracts, packaging or contract services. Prepare a shortlist by material or service, then compare each supplier against your actual requirements rather than collecting catalogues indiscriminately.

• Confirm product identity, grade, specifications and intended application.
• Ask which quality documentation and regulatory evidence can be reviewed.
• Compare minimum order quantities, available formats, capacity and lead times where the supplier can confirm them.
• Record whether the company is a manufacturer, distributor or service provider.

Pharma and biopharma manufacturers

Useful if your team is reviewing manufacturing inputs, production equipment, contract development or manufacturing options, or complementary partners. Bring the parts of your process that shape supplier fit: dosage form, process stage, scale range, technical constraints and quality requirements.

• Compare the scope of CDMO and contract-service capabilities, not just broad claims.
• Ask how equipment integrates with existing production and validation processes.
• Distinguish current capacity from planned capacity and request evidence for any critical capability.
• Identify which discussions merit technical review by quality, engineering or regulatory colleagues after the show.

Biopharma and biotechnology professionals

Useful if you are exploring biopharmaceutical services, manufacturing partnerships, technologies or sector developments. The 2026 programme included sessions on K-Bio innovative modalities; the 2027 agenda should be checked when published. Use the exhibition to identify relevant organisations and the programme to frame questions about technical or market developments.

• Clarify whether a supplier’s offer covers development, analytics, manufacturing or another defined stage.
• Ask about the molecule or process scope that is relevant to your project.
• Check how the supplier supports quality, scale-up and technology transfer.
• Separate exploratory conversations from partners ready for formal diligence.

Nutraceutical and health-functional-food businesses

Useful if your work involves health-functional-food ingredients, formulations, products or services. Health-functional-food visitors accounted for 34.4% of reported visitor interest in 2026, according to the organiser. Match ingredient conversations to intended product use, evidence needs, formulation constraints and the regulatory framework in your target markets.

• Compare ingredient forms, composition and technical data.
• Ask what substantiation and quality documents are available.
• Discuss formulation compatibility, supply continuity and commercial scale.
• Use relevant policy or market sessions as context, not as a substitute for regulatory advice.

Laboratory, analytical and packaging specialists

Useful if you evaluate laboratory or analytical equipment, packaging, drug-delivery systems or related production support. Reported 2026 visitor interest included laboratory/analytical equipment and packaging. Bring measurable requirements—throughput, method, format, compatibility or operating constraints—so demonstrations and supplier discussions can be compared consistently.

• Ask what sample, method or production conditions the equipment supports.
• Compare compatibility, installation requirements and service support.
• For packaging or delivery systems, check material, format, application and line-integration questions.
• Capture any technical documentation that needs review by your engineering or quality team.

What can you find at CPHI Korea?

The organiser’s current event materials group the exhibition around pharma ingredients, API and FDF; nutraceutical ingredients and FDF; biopharma; contract services; and laboratory machinery and equipment. Its sector list also names packaging and drug delivery, excipients, integrated pharma, natural extracts and fine chemicals.

Pharmaceutical ingredients and finished dosage

• APIs and fine chemicals: discuss identity, purity, grade, application, documentation and supply conditions.
• Excipients: compare functional role, specifications, compatibility and available formats.
• Finished dosage forms: review product scope, presentation, manufacturing arrangements and market requirements.
• Natural extracts: clarify source, composition, standardisation and documentation relevant to the intended use.

Biopharma, nutraceuticals and contract services

• Biopharma: identify organisations whose stated capabilities align with your project stage.
• Nutraceutical ingredients and FDF: compare ingredient and product options for health-functional-food applications.
• Contract services: determine whether the provider covers development, manufacturing, testing or another service needed by your team.
• Integrated pharma: investigate the specific production or supply-chain capability behind each company’s offer.

Equipment, packaging and drug delivery

• Laboratory machinery and equipment: ask about methods, throughput, installation and support.
• Packaging: compare formats and materials against product protection, line fit and market requirements.
• Drug delivery: assess the technology and application, then identify which technical and regulatory teams should review it.

These categories describe the organiser’s published scope. They do not establish that every product or service will be represented in every year, so check the 2027 exhibitor list and floor information when available.

What makes CPHI Korea distinctive?

Its value comes from the breadth of connected pharma and bio categories combined with structured business engagement. The 2026 edition brought together 478 exhibiting companies from 22 countries, with visitors from 65 countries, according to the official post-show report. The organiser also reported more than 13,000 meeting requests and over 700 business meetings through its 1:1 matchmaking platform in 2026. These figures describe that edition only; they do not guarantee access, meetings or commercial outcomes in 2027.

For visitors, the combination can support a comparison that extends beyond a single ingredient or technology: a sourcing question may involve material, formulation, contract services, equipment and packaging together. For exhibitors, a broad professional audience can make it worthwhile to prepare separate conversations for purchasers, technical specialists and potential partners. The 2027 edition is planned to use COEX Hall D and Grand InterContinental Seoul Parnas, giving the event an expanded venue arrangement. Confirm the latest map and meeting locations before finalising your daily route.

What should you try to achieve at CPHI Korea?

Replace the vague goal of “seeing what is new” with a decision you can evaluate afterward. Set one primary objective and two secondary objectives for each day.

If you are a buyer or procurement professional

Example objective: shortlist three suppliers for a defined ingredient or service and record the evidence needed for qualification. Capture the product, specification, documentation, supply conditions and next action for each conversation.

If you are a manufacturer or technical leader

Example objective: identify two equipment, CDMO or technology options that merit a technical review. Bring the process or project constraints that determine fit, and note which colleagues should assess each option.

If you work in biopharma or nutraceuticals

Example objective: map a small set of potential partners or product inputs to a specific development, sourcing or market question. Distinguish a useful introduction from a verified capability and plan the evidence you need before progressing.

If you exhibit

Example objective: identify the visitor types and use cases your team most needs to reach. Prepare a concise product explanation, the questions that qualify a prospect, and a clear next step that does not overpromise.

At the end of the show, success is a decision-ready set of comparisons, contacts and follow-up tasks—not the number of stands visited.

How to prepare before CPHI Korea

1. Define requirements before searching

Write down the product, service or partnership need in operational terms. For materials, include intended application, form, grade, specification and documentation requirements. For machinery, include the method or process stage, throughput, integration constraints and service expectations. For CDMO or contract services, identify project stage, scope, scale and quality requirements. Keep confidential information out of casual conversations until your organisation has agreed how to share it.

2. Build a supplier shortlist

Use the official 2027 exhibitor directory and event information when the organiser publishes them. The available directory link may relate to a previous edition, so confirm its year before using it as a current list. Mark each target as A—essential, B—useful, or C—explore if time allows. Group targets by sector and venue location so you can avoid unnecessary backtracking.

3. Request or schedule meetings thoughtfully

The organiser describes a Hosted Buyer Programme with an application and an online matchmaking platform. Programme participation is subject to selection and its stated conditions; do not assume a place or meeting. If the 2027 matchmaking platform opens, identify the suppliers you want to meet, explain your requirement in a concise brief, and reserve time to follow up on conversations that need technical colleagues.

4. Prepare questions for suppliers

• What exactly is the product, service or equipment scope?
• Which specification, grade, dosage form or process range applies?
• What quality, regulatory or technical documentation can you share?
• What manufacturing, testing or service capacity is available now?
• What is the minimum order, batch or project scope?
• What lead-time assumptions and supply terms should we compare?
• Which markets or applications are supported, and what evidence can you provide?
• What site audit, sample, validation or technical review would be needed next?
• Who should join a follow-up discussion from our quality, engineering, sourcing or regulatory teams?

5. Use the programme to sharpen your questions

In 2026, the organiser ran conferences, seminars and IR pitches, including sessions on bio-health policy, innovative modalities, AI drug discovery and microneedle technology. Check the 2027 programme when it is published; select sessions that address an actual information gap and leave time for the meetings that support your objective.

6. Plan around the expanded venue

The organiser announced COEX Hall D and Grand InterContinental Seoul Parnas for 2027. Check which exhibitors, sessions and meetings are assigned to each location. Build realistic transitions into your plan, and verify the current venue map, entrance information and daily opening schedule shortly before travelling.

How to make the most of the exhibition

Use one record for every supplier or partner conversation. A consistent format makes comparisons more useful after several busy days.

• Company and contact: who you spoke with and their role.
• Product or service: exact category, product name and scope.
• Why relevant: the requirement or project it may address.
• Evidence to review: specification, quality documents, capacity, sample or technical information requested.
• Commercial questions: minimum order, service scope, lead time or terms still to confirm.
• Next action: who will follow up, what they need, and by when.

For an API discussion, for example, note the required grade and intended use separately from the supplier’s description, then list the quality and regulatory documents your team must assess. For a machine or analytical system, capture method, throughput and integration points rather than relying on a general demonstration. For a CDMO conversation, record the project stage and service boundary so later comparisons are like-for-like.

Use the event’s official matchmaking platform if it is available to you, but treat a meeting as an introduction rather than a completed qualification. Ask permission before sharing sensitive specifications or project details, and route consequential claims to the appropriate technical, quality and regulatory review.

Plan your three days at CPHI Korea

The 2027 event runs for three days. A three-day visit can be useful when your objectives span sourcing, technical evaluation and programme learning, but the best schedule depends on the exhibitors and agenda actually announced.

Before the first day

• Confirm the venue map and identify which targets are in COEX Hall D and which are at Grand InterContinental Seoul Parnas.
• Mark fixed appointments and high-priority sessions first.
• Keep a short list of questions for each category: ingredients, biopharma, contract services, equipment or packaging.

During the first day

Orient yourself to the venue arrangement, attend any essential opening appointments, and focus on your highest-priority suppliers. Record evidence and next actions while conversations are fresh. Do not fill every gap in the schedule; leave time for a supplier meeting to run long or for a session to raise a new question.

During the second day

Use the day for deeper comparisons and cross-functional conversations. Revisit the strongest options with colleagues, attend relevant technical or market sessions if announced, and identify claims that require documents or a formal follow-up rather than an immediate conclusion.

During the final day

Close gaps in your shortlist, confirm contact details and agree what information will be exchanged next. Review your notes before leaving so that the most promising contacts do not get lost among brochures. The organiser’s published schedule currently lists shorter hours for the last day than the first two; reconfirm 2027 opening times before your visit.

Beyond the CPHI Korea exhibition floor

The previous edition shows the range of programme formats that may complement supplier visits. CPHI/Hi Korea 2026 recorded 41 conferences, 70 seminars and 33 IR pitching sessions. Organiser-reported themes included health-functional-food policy, the Bio-Health Policy Forum, K-Bio innovative modalities, AI drug discovery and microneedle technology. These are 2026 examples, not promises for 2027.

When the 2027 agenda is released, compare session descriptions with the questions in your preparation list. A policy or market session may help frame a discussion; a technical presentation may point you toward a method or development area worth investigating. Take notes on the specific claim, its source and the implication for your work, then verify consequential details with original documentation or your internal experts.

The event’s IR pitching sessions in 2026 provided a format for company presentations. If a similar format returns, use it to identify organisations or technologies for further review, not as a substitute for due diligence. Check the organiser’s programme for the confirmed 2027 subjects, speakers, formats and timings.

Networking at CPHI Korea

Arrive with a short introduction that explains your role, the part of the pharma or bio supply chain you work in, and the requirement you are exploring. A focused opening helps the other person decide whether their offer is relevant. For a sourcing conversation, specify the material or service and the broad technical scope; for a partnership conversation, state the project stage and the capability you need.

Use the organiser’s matchmaking option if it is available to you. The Hosted Buyer Programme describes application, selection, pre-scheduled meetings and post-event meeting reports. Its benefits and eligibility apply only to selected participants under the programme’s terms. Meeting requests and reported meeting totals from 2026 show that structured matching was used in that edition, but they do not guarantee a meeting or business result for any participant.

• Ask concise questions and listen for the boundary of the supplier’s capability.
• Distinguish a verified fact from a projection, marketing claim or future plan.
• Write down the specific document or colleague needed for the next step.
• Agree a follow-up action rather than ending with an open-ended promise.
• Protect confidential information and follow your organisation’s compliance requirements.

What visitors should know about access and logistics

CPHI Korea 2027 is announced for COEX Hall D and Grand InterContinental Seoul Parnas in Seoul. This is a multi-location venue arrangement, so do not assume that every exhibitor, session or meeting will be in the same building. Check the organiser’s current map, entrance details, event notices and schedule before setting appointments or arranging local movements.

The organiser’s event pages provide a venue map and travel-guide entry point, but the exact 2027 access and transport arrangements should be checked against current official instructions. Build flexibility into the timetable between appointments at the two locations. If you have accessibility or equipment requirements, contact the organiser and venue in advance rather than relying on assumptions about entrances or facilities.

Confirm registration status and any event-specific entry requirements directly with the organiser. The 2027 page offers a registration-interest route; check whether full visitor registration, fees and terms have been published before making plans. This guide does not establish ticket prices or registration deadlines.

How long should you spend at CPHI Korea?

CPHI Korea is scheduled across three days and the organiser describes a broad sector mix, structured matchmaking and a substantial previous-edition programme. Choose the duration based on your shortlist and the 2027 agenda rather than trying to cover every stand.

• One day: may suit visitors with a narrow sourcing question, a small set of pre-arranged meetings and no need to compare several technical categories. Prioritise appointments and essential sessions.
• Two days: may suit buyers comparing suppliers across related categories, or teams combining supplier meetings with programme sessions. Use the first day to screen options and the second to revisit the most relevant discussions.
• Three days: may be useful when you need to cover multiple supply-chain areas, attend selected sessions and conduct follow-up conversations across the two announced venue locations. Keep the final day for unresolved questions and next-step agreements.

These are planning approaches, not guarantees about the final floor layout or programme. The 2027 exhibitor list, session schedule and meeting availability should determine your final plan.

CPHI Korea is particularly valuable if you have a defined project

A live development, sourcing or production project makes it easier to judge whether a supplier conversation is useful. Prepare a non-confidential project brief with only the details needed to establish fit.

• For ingredients: intended application, required form or grade, key specification, quality documentation and target supply scale.
• For finished dosage or formulation: dosage form, process constraints, packaging needs and the capabilities that remain unresolved.
• For biopharma or CDMO services: development stage, service scope, technical requirements and the next evidence needed for qualification.
• For laboratory and analytical equipment: method, sample type, throughput, integration constraints and support expectations.
• For packaging and drug delivery: product format, material or delivery requirement, compatibility questions and intended use.
• For nutraceuticals: ingredient purpose, formulation considerations, available quality and substantiation documents, and target-market requirements.

Keep commercially sensitive details within your approved disclosure process. A trade-show conversation can help you identify whether a potential fit exists; it cannot replace internal technical, quality, regulatory, legal or procurement review.

Who should consider exhibiting at CPHI Korea?

The organiser’s published sectors include manufacturers and suppliers of APIs, finished dosage, excipients, fine chemicals, natural extracts, nutraceutical ingredients, biopharma products and services, contract services, laboratory machinery, packaging and drug delivery. Companies should judge the fit against their target customers and the specific capability they can explain and support.

• Pharmaceutical ingredient and API manufacturers or distributors with clear product specifications and documentation.
• Finished-dosage and integrated-pharma companies seeking relevant commercial or technical conversations.
• Biopharma companies, CDMOs and other contract-service providers able to define their service scope.
• Nutraceutical and health-functional-food ingredient or product suppliers.
• Laboratory, analytical, production-equipment, packaging and drug-delivery solution providers.
• Specialist suppliers of excipients, fine chemicals and natural extracts for pharmaceutical or health applications.

The organiser reported that 478 companies from 22 countries exhibited in 2026 and announced a 2027 expectation of more than 450 exhibitors. The former is a reported result; the latter is a forecast. Before exhibiting, set a measurable objective such as a target number of qualified conversations, distributor discussions or technical follow-ups. Identify which visitor roles matter, prepare evidence for product claims, and decide how your team will record and route leads. No exhibition can guarantee qualified leads, contracts or market access.

Questions for an exhibitor team

• Which product or service should each team member lead with?
• What documentation can be shared at the stand, and what requires approval?
• Which prospects need a technical, quality, regulatory or commercial colleague?
• How will the team record requirements, decision roles and next actions?
• What follow-up response can you reliably provide after the exhibition?

CPHI Korea visitor checklist

Before the event

• ☐ Define a primary sourcing, technical, partnership or market-learning objective.
• ☐ Check the year and status of exhibitor lists, registration information and programme pages.
• ☐ Shortlist companies by product category and priority.
• ☐ Prepare questions about specifications, documentation, capacity, service scope and supply terms.
• ☐ Apply for the Hosted Buyer Programme only if you meet its criteria and can comply with its terms.
• ☐ Confirm the 2027 venue map, daily opening hours and locations for appointments.
• ☐ Schedule internal reviews for contacts that need technical or quality follow-up.

During the event

• ☐ Check each product or service against your written requirement.
• ☐ Record the evidence offered and the evidence still needed.
• ☐ Separate confirmed capability from estimates, future plans or promotional language.
• ☐ Note which venue location hosts each appointment, and leave time for transitions.
• ☐ Attend sessions that answer a defined question and capture their sources.
• ☐ Confirm the next action and responsible contact before ending a useful conversation.

After the event

• ☐ Classify contacts as immediate review, potential fit or market intelligence.
• ☐ Send the requested technical documents or meeting follow-up promptly.
• ☐ Route quality, regulatory, engineering and commercial claims to the right reviewers.
• ☐ Compare suppliers using the same specification and service criteria.
• ☐ Record unresolved questions and decide whether samples, audits or formal proposals are appropriate.

Is CPHI Korea worth visiting?

CPHI Korea is most useful for people with a defined pharmaceutical, biopharmaceutical, nutraceutical, laboratory or packaging requirement and enough preparation time to compare suppliers. Its published categories cover multiple parts of the supply chain, while the 2026 edition’s reported visitor and exhibitor figures show a substantial international business event. Buyers can use it to identify options and organise the evidence needed for further evaluation; manufacturers and technical teams can examine services, equipment and partnerships; exhibitors can present a focused offer to relevant professional audiences.

The return depends on fit, preparation and follow-up. Walking the exhibition without a shortlist may produce many contacts but few decision-ready comparisons. Check the 2027 exhibitor list, programme, venue map and registration terms when available, and decide whether the published information supports your particular objective.

CPHI Korea 2027 at a glance

Dates and the expanded venue arrangement are announced for 2027. Attendance and exhibitor figures above are from the 2026 post-show report; 2027 scale figures are organiser expectations.

Make your CPHI Korea visit purposeful

Start with the decision you need to make, then use the exhibition, programme and structured meetings to gather comparable evidence. Keep technical and commercial questions specific, verify claims that matter to your organisation, and agree a practical follow-up for every promising conversation.

Define. Compare. Verify. Connect. Follow up.

Pharmaceutical and biopharma opportunities in South Korea

Market context

South Korea’s pharmaceutical export activity provides relevant context for companies evaluating this event’s ingredient, finished-dose, biopharma and contract-service sectors. The Ministry of Health and Welfare reported that pharmaceutical exports reached USD 10.4 billion in 2025, the first time they exceeded USD 10 billion. Biopharmaceuticals accounted for 62.6% of pharmaceutical exports, or USD 6.52 billion, according to the ministry’s 2025 export report published in March 2026. Those figures describe national exports, not the potential customer base for any particular exhibitor.

Possibilities for exhibitors

• Suppliers of APIs, excipients, fine chemicals, natural extracts and finished dosage may be able to use the show to explore whether their capabilities fit Korean manufacturers’ sourcing or partnership needs.
• Biopharma and contract-service companies could investigate potential collaborations related to development, manufacturing or international supply, subject to technical qualification and commercial diligence.
• Equipment, packaging and drug-delivery providers may explore how their solutions align with local production and export requirements; product fit and regulatory obligations need to be assessed individually.

Possibilities for visitors

• Purchasers could compare international and local suppliers for defined materials or services and identify what documentation is needed for a qualification process.
• Manufacturers may use the event to examine equipment, contract services or partner capabilities relevant to a project, while keeping capacity and compliance claims subject to verification.
• Biopharma and nutraceutical professionals may use the broader sector mix to identify adjacent technologies and potential partners worth evaluating.

South Korea may be relevant to companies seeking to understand an export-oriented pharmaceutical and biopharma environment, as reflected in the ministry’s 2025 figures. The event can support exploration and comparison, but suitability depends on each participant’s products, customers, quality evidence and market-entry requirements.

Discover Seoul

Seoul combines contemporary commercial districts with historic palaces and cultural sites. The venue arrangement for CPHI Korea 2027 includes COEX Hall D and Grand InterContinental Seoul Parnas in the city’s Gangnam-gu district; the attractions below are elsewhere in Seoul or within the COEX complex, so check locations and schedules before fitting them around event commitments.

Starfield Library

Located inside COEX Mall, Starfield Library is a public reading and gathering space with large open bookshelves. It offers an easy cultural pause within the same complex as the event’s COEX venue.

Gyeongbokgung Palace

The official Visit Seoul guide describes Gyeongbokgung as the first and largest of the royal palaces built during the Joseon Dynasty. Its historic architecture offers a different perspective on the city from the modern business district around the exhibition.

Namsan Seoul Tower

Visit Seoul identifies Namsan Seoul Tower as a landmark originally built in 1969 as Korea’s first integrated transmission tower. It provides a recognisable city attraction for visitors who have time to explore beyond the exhibition.

With appointments split between COEX Hall D and Grand InterContinental Seoul Parnas, keep business travel arrangements tied to the event map. If your schedule allows, choose one city visit that suits your interests rather than trying to fit several distant stops into a crowded fair day.